Lamotrigine Tablet
Product Images NDC 55154-2065

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 55154-2065). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1

A Kaplan-Meier failure probability curve comparing Lamotrigine and placebo over 100 weeks. The y-axis represents failure probability (%) and the x-axis represents time in weeks. Two distinct lines show failure rates for Lamotrigine and placebo groups, with censored data points marked.*

FDA Label Image

Figure 2

A Kaplan-Meier failure probability curve comparing Lamotrigine and placebo over approximately 80 weeks. The y-axis shows failure probability in percentage, and the x-axis shows time in weeks. The graph includes censored data points and shows Lamotrigine's failure probability generally lower than placebo over time.*

FDA Label Image

Structure

Chemical structure of lamotrigine, showing its chlorinated phenyl and triazine ring components with amine groups, corresponding to the active ingredient lamotrigine.*

FDA Label Image

Tablets For Suspension

A comparison of tablet imprints describing the physical characteristics of two Lamotrigine oral tablets: a 5 mg tablet labeled with "Z" on one side and "13" on the other, white to off-white; and a 25 mg tablet labeled with "Z" and "12," also white to off-white, both debossed.*

FDA Label Image

Tablets

This image displays a table showing imprints and descriptions of Lamotrigine tablets at various strengths: 25 mg, 50 mg, 100 mg, 150 mg, 200 mg, and 250 mg. Each tablet is described as white to off-white, with one side bisected, debossed with "ZC," and the other side debossed with the respective strength number (e.g., "79" for 25 mg).*

FDA Label Image

D3b13712 45d4 3347 E053 2a95a90aa915 00

Lamotrigine tablets, USP 100 mg oral tablets, package containing 10 tablets. The label includes storage instructions, dosage warnings, pharmacist dispensing cautions, and a note that the unit dose package is not child-resistant, intended for institutional use. Distributed by Cardinal Health 107, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.